New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
When cells go boom: Study reveals inflammation-causing gene carried by millions

When cells go boom: Study reveals inflammation-causing gene carried by millions

byWalter and Eliza Hall InstituteCredit: WEHIAustralian researchers at Walter and Eliza Hall Institute (WEHI) have found that a genetic change that increases the risk of inflammation, through a
inflammatory disease January 29,2024
When cells go boom: Study reveals inflammation-causing gene carried by millions

When cells go boom: Study reveals inflammation-causing gene carried by millions

byWalter and Eliza Hall InstituteCredit: WEHIAustralian researchers at Walter and Eliza Hall Institute (WEHI) have found that a genetic change that increases the risk of inflammation, through a
inflammatory disease January 29,2024
Bacterial enzyme research paves the way for acne vaccine

Bacterial enzyme research paves the way for acne vaccine

by Sara Bock, University of CaliforniaComparison of HylA and HylB with bacterial and animal Hyl. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-43833-8In a groundbreaking deve
inflammatory disease January 29,2024
Bacterial enzyme research paves the way for acne vaccine

Bacterial enzyme research paves the way for acne vaccine

by Sara Bock, University of CaliforniaComparison of HylA and HylB with bacterial and animal Hyl. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-43833-8In a groundbreaking deve
inflammatory disease January 29,2024
Atopic dermatitis: Viruses discovered as new therapy option

Atopic dermatitis: Viruses discovered as new therapy option

by Medical University of ViennaStudy workflow and bacterial communities in healthy skin and AD. (A) Study workflow. (B) Ridge plot displaying the distribution of samples depending on the fraction
inflammatory disease January 29,2024
Atopic dermatitis: Viruses discovered as new therapy option

Atopic dermatitis: Viruses discovered as new therapy option

by Medical University of ViennaStudy workflow and bacterial communities in healthy skin and AD. (A) Study workflow. (B) Ridge plot displaying the distribution of samples depending on the fraction
inflammatory disease January 29,2024
Neuronal sensing of cytokine IL-12 induces tissue adaptation and protects mice from neuroinflammation

Neuronal sensing of cytokine IL-12 induces tissue adaptation and protects mice from neuroinflammation

by Ingrid Fadelli , Medical XpressRepresentative immunolabeling of IL-12Rβ2+(βgal+) NeuN+neuronal cells in the inflamed murine hippocampus (left) and cerebellum (right) of Il12rb2LacZ/LacZ
inflammatory disease January 29,2024
Neuronal sensing of cytokine IL-12 induces tissue adaptation and protects mice from neuroinflammation

Neuronal sensing of cytokine IL-12 induces tissue adaptation and protects mice from neuroinflammation

by Ingrid Fadelli , Medical XpressRepresentative immunolabeling of IL-12Rβ2+(βgal+) NeuN+neuronal cells in the inflamed murine hippocampus (left) and cerebellum (right) of Il12rb2LacZ/LacZ
inflammatory disease January 29,2024
An itching paradox—a molecule that triggers the urge to scratch also turns down inflammation in the skin

An itching paradox—a molecule that triggers the urge to scratch also turns down inflammation in the skin

by Marlys Fassett,The ConversationCredit: CC0 Public DomainItching can be uncomfortable, but it's a normal part of your skin's immune response to external threats. When you're itchin
inflammatory disease January 29,2024
An itching paradox—a molecule that triggers the urge to scratch also turns down inflammation in the skin

An itching paradox—a molecule that triggers the urge to scratch also turns down inflammation in the skin

by Marlys Fassett,The ConversationCredit: CC0 Public DomainItching can be uncomfortable, but it's a normal part of your skin's immune response to external threats. When you're itchin
inflammatory disease January 29,2024
Newly discovered compound blocks signaling pathway of immune response

Newly discovered compound blocks signaling pathway of immune response

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesSLC15A4-TASL binding interface and drug screening for TASL stability. Credit:Nature Communications(2023).
inflammatory disease January 29,2024
Newly discovered compound blocks signaling pathway of immune response

Newly discovered compound blocks signaling pathway of immune response

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesSLC15A4-TASL binding interface and drug screening for TASL stability. Credit:Nature Communications(2023).
inflammatory disease January 29,2024
Uncovering the role of skin microbiome and immune response in cutaneous leishmaniasis

Uncovering the role of skin microbiome and immune response in cutaneous leishmaniasis

by Abbey Porter,University of PennsylvaniaPredominant colonization with Staphylococcus is associated with delayed healing time and disturbed microbiome recovery. Credit:Science Translation
inflammatory disease January 29,2024
Uncovering the role of skin microbiome and immune response in cutaneous leishmaniasis

Uncovering the role of skin microbiome and immune response in cutaneous leishmaniasis

by Abbey Porter,University of PennsylvaniaPredominant colonization with Staphylococcus is associated with delayed healing time and disturbed microbiome recovery. Credit:Science Translation
inflammatory disease January 29,2024
Study finds early anti-inflammatory treatment is best protection for the newborn brain

Study finds early anti-inflammatory treatment is best protection for the newborn brain

by Hudson Institute of Medical ResearchOutline of systemic and central nervous system inflammatory responses targeted by the immune-based therapeutics identified in this systematic review. Create
inflammatory disease January 29,2024
Study finds early anti-inflammatory treatment is best protection for the newborn brain

Study finds early anti-inflammatory treatment is best protection for the newborn brain

by Hudson Institute of Medical ResearchOutline of systemic and central nervous system inflammatory responses targeted by the immune-based therapeutics identified in this systematic review. Create
inflammatory disease January 29,2024
BNP peptide found to be a culprit in eczema

BNP peptide found to be a culprit in eczema

by Tracey Peake,North Carolina State UniversityCredit: Unsplash/CC0 Public DomainResearchers from North Carolina State University have pinpointed a particular peptide's role in activating at
inflammatory disease January 29,2024
BNP peptide found to be a culprit in eczema

BNP peptide found to be a culprit in eczema

by Tracey Peake,North Carolina State UniversityCredit: Unsplash/CC0 Public DomainResearchers from North Carolina State University have pinpointed a particular peptide's role in activating at
inflammatory disease January 29,2024
Cholesterol and inflammation demonstrate Alzheimer's link

Cholesterol and inflammation demonstrate Alzheimer's link

by Alzheimer's Center at Temple University Lewis Katz School of MedicineReduced ABCA7 protein levels after cholesterol depletion in human C20 and HMC3 microglia cells. (A) C20 cells treated with t
inflammatory disease January 29,2024
Cholesterol and inflammation demonstrate Alzheimer's link

Cholesterol and inflammation demonstrate Alzheimer's link

by Alzheimer's Center at Temple University Lewis Katz School of MedicineReduced ABCA7 protein levels after cholesterol depletion in human C20 and HMC3 microglia cells. (A) C20 cells treated with t
inflammatory disease January 29,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com